Triallate

Triallate

SCHEMBL28134685

C1CCCCC1.CC(C)N(C(=O)SCC(Cl)=C(Cl)Cl)C(C)C

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triallate SCHEMBL8537965 0.94
Triallate SCHEMBL909879 0.93
Triallate SCHEMBL973423 0.93
Triallate SCHEMBL17110498 0.93
Triallate SCHEMBL3089362 0.93
Triallate SCHEMBL11670923 0.91
Triallate SCHEMBL17700977 0.91
Triallate SCHEMBL3787679 0.91
Triallate SCHEMBL10795895 0.89
Triallate SCHEMBL20636814 0.89 SMN1; SMN2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109970760-A ACC inhibitor and its purposes 吉利德阿波罗公司 2019-07-05 CN disclosed
CN-106905346-B ACC inhibitor and its purposes 吉利德阿波罗公司 2019-05-28 CN disclosed
CN-106905346-A ACC inhibitor and its purposes 吉利德阿波罗公司 2017-06-30 CN disclosed
CN-104105485-B Acc inhibitors and uses thereof 吉利德阿波罗公司 2017-04-12 CN disclosed